Cost-effectiveness of dengue vaccination in ten endemic countries

Overview of attention for article published in Vaccine, December 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

policy: 2 policy sources
twitter: 7 X users

facebook: 1 Facebook page

Readers on

mendeley: 202 Mendeley

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 40,032 followers.

Se estima que la vacunación del dengue a los 9 años permitiría reducir el coste per cápita en un 22-23%. Este estudio se ha llevado a cabo en 10 países endémicos #microC2018 https://t.co/nOdEv8swA0

The negative hype about the Dengvaxia dengue vaccine has obscured the fact that it COULD be a very valuable asset in the fight against a deadly disease. https://t.co/6nEqOhOF0Q

Cost-effectiveness of dengue vaccination in ten endemic countries 💉 https://t.co/xLat103kZn

Cost-effective of #dengue vaccines study results: •Routine vax at age 9 would avert 22–23% of dengue illness costs. •Vaccination would be cost effective or highly cost effective in all remaining sites of study in @ELSpharma #vaccine https://t.co/WOdx55Jh…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 3 additional X posts.